The PharmSource Lead Sheetis the key to building your pipeline of new business
From the global bio/pharmaceutical industry’smost respected provider of market intelligence
A GlobalData company
Pharma | Biotech | Medtech | Devicewww.PharmSource.com
“I use it every week to evaluate new opportunities and utilize the contact information. This has led to many important meetings and opportunities.”
—VP of Business Development, Global CRO
Here’s what clients like best about the PharmSource Lead Sheet:
“ ”
Turning information into intelligence . . .The PharmSource Lead Sheet is built to help you acquire new business. Everything you need is in this single robust resource.
t
The Lead Sheet is accurate – very, very reliable and a huge time saver. This is a permanent resource for us.
– VP of BD, top-10 global CMO
In less than four months . . . weconverted a lead to an awarded early phase study for over $3M. That’s an impressive ROI that competing services are unable to replicate.
– Dir., Global Marketing, US-based CRO
It keeps me aware of smaller com-panies not necessarily on my radar. I’ve landed valuable new accounts from this.
– Dir. of BD, UK-based CDMO
Novogen Ltd.
Blue links show confirmed emails; green links show probable emails.
CORPORATE:
q James Garner, CEOq Cristyn Humphreys, CFOq Lionel Mateo, Company Secretary
RESEARCH
q David Brown, CSOq Stephen Palmer, PhD, Director, Degenerative Diseases Programq Justine Stehn, PhD, Director, Anti-Tropomyosin (ATM) program
PRECLINICAL
q Andrew Heaton, PhD, VP, Drug Discovery
REGULATORY
q Kimberly Lilischkis, Manager, Clinical and Regulatory Affairs
Follow products on the moveVerified contact details
Sirnaomics, Inc.
Sirnaomics advances RNAi technology, using proprietary positions in high-throughput siRNA inhibitor identification, multi-targeted siRNA cocktail discovery and nanoparticle-enhanced siRNA delivery for development of gene-targeted therapeutics.
www.simaomics.com/
Qualifying Information
API Focus: Nucleic Acid
OwnershIp: Private corporation
Recent Drug Highlights: Click to view past 12 months of lead history on this company.
Location(s)
Headquarters401 Professional Dr., Suite 130 Phone: +1-301-740-1370Gaithersburg, MD 20879 USA Fax: +1-301-740-1371
Standard Email Format: [email protected]
OtherSuite A3-207, 218 Xinghu Street, BioBay Phone: +86 512 6295 6283215123 Suzhou Industrial Park China Fax: +86 512 6295 6284
Corporate Email: [email protected]
Contact Info
Blue links show confirmed emails; green links show probable emails.
CORPORATE:
q Patrick Y. Lu, President & CEOq Marc M. Lemaitre, PhD, COOq George J. Ji, SVP, Corporate Developmentq Harry H. Yang, SVP, Strategic Planning & Asia Operations
RESEARCH
q David M. Evans, VP, Discovery Researchq Alan Y. Lu, EVP, Product Development
CLINICAL RESEARCH
q Michael Molyneaux, MD, CMO
Company details
Set Filters View Criteria
Dosage Form
Semi-solid - Non-sterileTopical
Nature of API
Nucleic acid - RNA
Therapeutic Area
Vaccine (infectious target)
Dosage Form
Parenteral
Nature of API
Chemical- Normal potencyChemical - Cytotoxic
Therapeutic Area
Oncology - Chemotherapy
ClinicalTrials.govI
Company: Novogen Ltd. HQ Location: Hornsbey, NSW, Australia Product: Cantrixil Comment: Novogen plans to initate a
Phase 1 trial in H2 of 2016 with Cantrixil for the treatment of refractory or recurrent peri-toneal cancers with malignant ascites. The cyclodextrin-based product contains the active ingredient TRXE-002-1, a low molecular weight super benzo-pyran molecule.
Company: Pharos Biological HQ Location: Baltimore, MD Product: Zika virus vaccine Comment: Pharos plans to begin Phase I
trials with a Zika virus vaccine in the autumn of 2016.
Company: Sirnaomics, Inc. HQ Location: Gaithersburg, MD Product: STP705 Comment: Sirnaomics plans to initiate a
Phase I trial in H2 of 2016 with its lead product, STP705, a topically applied siRNA cream for the prevention and
Dosage Form
Unknown
Nature of API
Biologic - Vaccine - DNA
Therapeutic Area
Vaccine (infectious target)
I
Products in Pipeline - Preclinical
ClinicalTrials.gov
Follow the money
”
Feed your sales pipeline with accurate, timely informationP The latest clinical pipeline progress, new financings and
moreP Targeted searches and Excel exports for marketing,
territory intelligence and moreP Custom filters take you straight to your sweet spot
Power-up your selling process with key intelligenceP Accurate information and insights for sales callsP Verified contact information: names, titles, e-mail
addressesP CRM tools expedite data transfer
Respected and endorsed world-wide
Turning information into intelligence . . .
. . . Turning intelligence into salesWe don’t just report events – we reveal new opportunities. We give your BD team what they need to build the right relationships – and sell!
t
”“ We are nearly fully booked for the next 18+ months, with full credit going to the PharmSource Lead Sheet.
– VP, Sales & Marketing, US-based privately held CMO
Company: GrayBug Vision HQ Location: Redwood City, CA Description: GrayBug Vision raises $44.5 million
in a Series B venture capital investment. The proceeds will be used to fund clinical trials for their lead drug, GB-102.
Products: Pipeline snapshot Strategy: GrayBug developes products for
the treatment of eye diseases.
Company: Helix BioPharma Corp. HQ Location: Aurora, ON, Canada Description: Helix BioPharma raises $3.7 million
in a private placement. The netproceeds will be used for promising new immuno-oncology projects and ongoing clinical development programs.
Products: Pipeline snapshot Strategy: Helix BioPharma develops products
for the treatment and prevention of cancer, based on its proprietary
Know who has new money for product development
Zoom to newly financed, early-stage drug companies
In addition to the Drug Edition, our Devices & Diagnostics Edition covers this fast-growing segment.
t
Financing Type
Venture capital investment
Amount Raised
$44.50 million
E
Financing Type
Private equity placement
Amount Raised
$3.70 million
Corporate Deals - Corporate Finance
PharmSource Lead Sheet is the definitive source of targeted new business opportunities for CROs, CMOs and CDMOs around the world. It’s an exclusive service of PharmSource Information Services, Inc., the global leader in bio/pharmaceutical market intelligence since 1996. PharmSource brings together buyers and sellers of contract services for the development and manufacture of drugs, medical devices and diagnostics.
Dynamic dashboard
Robust searchable databases
Global coverage
To learn more, contact us today for a complimentary test drive.www.PharmSource.com | +1.888.777.9940 | +1.703.383.4903
FOLLOW US
LEADSHEET
A GlobalData company
Discover where the PharmSourceLead Sheet can lead you.
All the benefits of an in-house lead-generation staff – at a fraction of the cost! We provide the deep knowledge, insight and tools you need to prosper.
t
